Evaluation of an ultra-rapid antibiotic susceptibility testing method on positive blood cultures with Escherichia coli
Baltekin, O.; Johnsson, A. T. A.; Wong, A. Y. W.; Nilsson, K.; Mert, B.; Söderberg, L.; Wistrand-Yuen, E.; Özenci, V.
Show abstract
Blood stream infection (BSI) is related to high mortality and morbidity. Early antimicrobial therapy is crucial in treating patients with BSI. The most common Gram-negative bacteria causing BSI is Escherichia coli. Targeted effective treatment of patients with BSI is only possible if it is based on antibiotic susceptibility testing (AST) data after blood culture positivity. However, there are very few methods available for rapid phenotypic AST and the fastest method takes 4 h. Here we analyzed the performance of a 30 min ultra-rapid method for AST of E. coli directly from positive blood cultures (BC). In total, 51 positive BC with E. coli were studied, and we evaluated the ultra-rapid method directly on positive BC as well as on E. coli colonies cultured on agar plates. The results obtained by the new method were compared with disk diffusion. The method provided accurate AST result in 30 min to Ciprofloxacin and Gentamicin for 92% and 84% of the positive BC samples, respectively. For E. coli isolates retrieved from agar plates, 86% and 96% of the AST results were accurate for Ciprofloxacin and Gentamicin, respectively, after 30 min of assay time. When time to result was modulated in-silico from 30 to 60 minutes for the agar plate samples, accuracy of AST results went up to 92% for Ciprofloxacin and to 100% for Gentamicin. The present study shows that the method is reliable and delivers ultra-rapid AST data in 30 minutes directly from positive BC and as well as from agar plates.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Evaluation of flow cytometry for cell count and detection of bacteria in biological fluids. 96%
- Direct colorimetry of imipenem decomposition as a novel cost effective method for detecting carabapenamase producing bacteria 96%
- Validation of selective agars for detection and quantification of Escherichia coli resistant to critically important antimicrobials 96%
Similar papers in this journal
- Evaluation of bacterial proliferation with a microfluidic-based device: Antibiochip. 97%
- Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system 96%
- Occurrence, identification and antibiogram signatures of selected Enterobacteriaceae from Tsomo and Tyhume rivers in the Eastern Cape Province, Republic of South Africa. 95%
Similar papers in this journal
- A multicenter evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections 98%
- resaCPE: A Rapid, Low-Cost Colourimetric Assay for the Detection of Carbapenemase-Producing Enterobacterales 96%
- Poloxamer dilution as an on-demand alternative to agar dilution-based antimicrobial susceptibility testing 95%
Similar papers in this journal
- False-positive detection of Group B Streptococcus (GBS) in chromogenic media due to presence of Enterococcus faecalis in High Vaginal Swabs 94%
- Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR 93%
- Optimization and validation of a quadruplex real-time PCR assay for the diagnosis of diphtheria 93%
Similar papers in this journal
- Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an Emergency Department 94%
- Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection 94%
- Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.